Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Cardax, Inc. CDXI OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
27/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cardax, Inc. (CDXI) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 25/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is 63.6% (+12.2 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 50/100 (Partial), Future ?/100 (Fail), Income ?/100 (Fail).

CDXI SharesGrow Score Overview

54/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CDXI

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
CDXI: -62.1%/yr revenue is, +36%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
~
MOAT Partial
50/100
CDXI: Gross margin is 63.6% (+12.2 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.004
Volume1
Avg Volume (30D)14
Market Cap$80.00
Beta (1Y)-13.76
Share Statistics
IPO Date2013-03-06
Employees10
CEODavid G. Watumull
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS14141D2018

Price Chart

Track all markets on TradingView
CDXI
Cardax, Inc. ↗  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.00

People Also View

MDGL
MDGL
Madrigal Pharmaceuticals, Inc.
$524.99
-0.13%
 KRYS
KRYS
Krystal Biotech, Inc.
$270.00
+0.97%
 PTCT
PTCT
PTC Therapeutics, Inc.
$73.01
+3.68%
 SRPT
SRPT
Sarepta Therapeutics, Inc.
$22.15
+1.65%
 IOVA
IOVA
Iovance Biotherapeutics, Inc.
$3.64
+5.20%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message